Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

73.07
Delayed Data
As of Jan 13
 -0.29 / -0.40%
Today’s Change
70.83
Today|||52-Week Range
103.10
+2.04%
Year-to-Date
Donald Trump Just Leveled Drug Companies With These 4 Words
Jan 14 / MotleyFool.com - Paid Partner Content
Why Ariad Pharmaceuticals Stock Soared Today
Jan 09 / MotleyFool.com - Paid Partner Content
Rhenman & Partners Asset Management AB Buys Gilead Sciences Inc, Medtronic PLC, Pfize...
Jan 13 / GuruFocus News - Paid Partner Content
Top Biotech Resolutions for 2017
Jan 09 / MotleyFool.com - Paid Partner Content
Jerome Dodson Buys Allergan PLC, McKesson Corp, Progressive Corp, Sells Ciena Corp, C...
Jan 12 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Gilead Sciences, Pepsi, United Parcel Services, Tw...
Jan 09 / Zacks.com - Paid Partner Content
Trump Attacks Biotech & Pharma: ETFs Bleed
Jan 12 / Zacks.com - Paid Partner Content
2017 J.P. Morgan Healthcare Conference Roundup
Jan 09 / MotleyFool.com - Paid Partner Content
Stock Market News for January 12, 2017
Jan 12 / Zacks.com - Paid Partner Content
Allergan Is a Blueprint for Gilead
Jan 09 / TheStreet.com - Paid Partner Content
Is the Options Market Predicting a Spike in Gilead Sciences (GILD) Stock?
Jan 12 / Zacks.com - Paid Partner Content
What If You Considered Gilead Sciences a Start-Up?
Jan 07 / MotleyFool.com - Paid Partner Content
Gilead (GILD) HBV Drug Vemlidy Receives European Approval
Jan 12 / Zacks.com - Paid Partner Content
Top Research Reports for Pepsi, UPS & Gilead Sciences
Jan 06 / Zacks.com - Paid Partner Content
Stock Market Roundup Jan. 11: Health Sector Lower on Trump "Murder" Comment
Jan 11 / Zacks.com - Paid Partner Content
Biotech Investing: 3 Bold Predictions for 2017
Jan 06 / MotleyFool.com - Paid Partner Content
Simplex Trading, Llc Buys SPDR S&P 500, Apple Inc, Alphabet Inc, Sells SPDR Gold Trus...
Jan 11 / GuruFocus News - Paid Partner Content
Gilead Sciences Inc.'s Biggest Failure in 2016
Jan 05 / MotleyFool.com - Paid Partner Content
Is This the Solution to Gilead Sciences' Woes?
Jan 10 / MotleyFool.com - Paid Partner Content
Why Gilead Sciences Lost a Staggering 29.2% In 2016
Jan 05 / MotleyFool.com - Paid Partner Content
4 Things Gilead Sciences' CEO Says to Expect in 2017
Jan 09 / MotleyFool.com - Paid Partner Content
Is Biogen Playing With Fire?
Jan 04 / MotleyFool.com - Paid Partner Content
The 10 Worst Stocks in the Nasdaq in 2016
Jan 09 / MotleyFool.com - Paid Partner Content
The 'final nail in the coffin' for Aids?
Jan 04 / FT.com - Paid Partner Content
So the Nasdaq Is At a Historical High but the Dow Is Going Opposite Direction
Jan 09 / TheStreet.com - Paid Partner Content
Stock Market News for January 04, 2017
Jan 04 / Zacks.com - Paid Partner Content
The Monday Sights, Sounds and Biotech Buzz from the J.P. Morgan Healthcare Conference
Jan 09 / TheStreet.com - Paid Partner Content
Forget Gilead Sciences Inc.: These 2 Stocks Doubled Last Year
Jan 02 / MotleyFool.com - Paid Partner Content